$TECH News

Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73

Bio-Techne Corrects Dividend Announcement

Techne (TECH) Q4 Earnings Meet Estimates

Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Bio-Techne Declares Dividend

Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate

Is Bio-Techne (TECH) Above Fair Value After A 44% Return?

JAZZ vs. TECH: Which Stock Is the Better Value Option?

Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases

What to Expect From Bio-Techne's Next Quarterly Earnings Report

Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks

RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73

Benchmark Downgrades Bio-Techne to Hold

Citigroup Downgrades Bio-Techne to Neutral, Raises Price Target to $73

Merck KGaA to acquire Bio-Techne in $11.3 billion deal

Bio-Techne (TECH) Agrees To $11.5 Billion Merck KGaA Buyout

Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73